US Stock MarketDetailed Quotes
ACHV Achieve Life
- 5.140
- +0.310+6.42%
Close Jul 23 16:00 ET
- 5.290
- +0.150+2.92%
Post 16:10 ET
176.51MMarket Cap-4079P/E (TTM)
5.270High4.810Low609.27KVolume4.810Open4.830Pre Close3.03MTurnover1.87%Turnover RatioLossP/E (Static)34.34MShares5.98052wk High3.57P/B167.23MFloat Cap3.03052wk Low--Dividend TTM32.54MShs Float1856247.281Historical High--Div YieldTTM9.52%Amplitude2.000Historical Low4.967Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Achieve Life Stock Forum
Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes
Achieve Life Sciences has initiated the ORCA-OL clinical trial to evaluate the long-term safety of cytisinicline, a treatment for smoking and nicotine dependence. The open-label trial involves 29 U.S. sites and aims to collect data required for a New Drug Application (NDA) submission expected in the first ...
NEWS
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...
No comment yet